Galena Biopharma to Present at the 20th Annual NewsMakers in the Biotech Industry Conference

Galena Biopharma, Inc.

PORTLAND, Ore., Sept. 23, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer will present a corporate update at the 20th Annual NewsMakers in the Biotech Industry Conference. The presentation will take place on Friday, September 27, 2013 at 3:00 p.m. ET at the Millennium Broadway Hotel in New York, NY.

The presentation will be webcast and available on the Investors section of the Company's website at www.galenabiopharma.com.

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit www.galenabiopharma.com.

CONTACT: Remy Bernarda Senior Director, Communications (503) 405-8258 rbernarda@galenabiopharma.com

Source:Galena Biopharma